Paclitaxel is a broad‐spectrum anticancer compound, which was derived mainly from a
medicinal plant, in particular, from the bark of the yew tree Taxus brevifolia Nutt. It is a …

The current achievements in treating glioblastoma (GBM) patients are not sufficient because
many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem …

CNS tumors remain among the deadliest forms of cancer, resisting conventional and new
treatment approaches, with mortality rates staying practically unchanged over the past 30 …

Cancer is a community health hazard which progress at a fatal rate in various countries
across the globe. An agent used for chemotherapy should exhibit ideal properties to be an …

Paclitaxel is one of the most effective chemotherapeutic drugs which processes the obvious
curative effect for a broad range of cancers including breast, ovarian, lung, and head & neck …

High-grade gliomas are still characterized by a poor prognosis, despite recent advances in
surgical treatment. Chemotherapy is currently practiced after surgery, but its efficacy is …

Cancer is the second most common cause of death globally, surpassed only by
cardiovascular disease. One of the hallmarks of cancer is uncontrolled cell division and …

Pancreatic cancer is one of the deadliest causes of cancer-related death in the United
States, with a 5-year overall survival rate of 6 to 8%. These statistics suggest that immediate …

Central nervous system disorders, especially neurodegenerative diseases, are a public
health priority and demand a strong scientific response. Various therapy procedures have …

Background Glioblastoma, or glioblastoma multiforme (GBM), remains a fatal cancer type
despite the remarkable progress in understanding the genesis and propagation of the tumor …